Oligonucleotide Synthesis global market

Oligonucleotide Synthesis global market

Global Oligonucleotide Synthesis Market Research Report 2026

Explore the latest insights on the Oligonucleotide Synthesis global market. Get detailed analysis on market size, share, industry trends, key drivers, competitive landscape, and future forecast up to 2030.

Pages: 210

Format: PDF

Date: 03-2026

Select Licence

Global Oligonucleotide Synthesis Market Strategic Report (2025–2036)

The global Oligonucleotide Synthesis market is undergoing a fundamental shift in 2026, transitioning from a research-heavy auxiliary sector to a cornerstone of the commercial pharmaceutical landscape. Driven by the "Genomic Blizzard" of the 2020s and the maturation of RNA-based therapeutics, the market is now characterized by high-volume GMP (Good Manufacturing Practice) production and the rapid adoption of Abuse-Deterrent and Targeted Delivery chemistries. As of Q2 2026, the industry is also actively mitigating the "Middle East Logistics Paralysis" caused by the escalating USA-Israel-Iran conflict, which has significantly impacted the global transshipment of cold-chain biological materials.


1. Executive Market Summary

The global Oligonucleotide Synthesis market is valued at approximately $12.81 Billion in 2026 and is projected to reach over $50 Billion by 2036, expanding at a robust CAGR of 18.8%.

While 2017 serves as the historical reference for standard primer and probe synthesis, the Base Year (2025) marks the era where Therapeutic-grade Oligos (ASOs, siRNAs, and CRISPR guides) surpassed Research-Use-Only (RUO) products in terms of total market value.

Key Market Projections

Metric

2024 (Estimated)

2025 (Base Year)

2036 (Forecast)

Market Value (USD)

$10.78 Billion

$11.60 Billion

$50.84 Billion

Dominant Segment

Research Primers

Therapeutic API

Commercial GMP Oligos

Primary Driver

Rare Diseases

Oncology/RNAi

Personalized Medicine


2. Segments Analysis

The market is bifurcating into high-throughput "Digital DNA" services and high-complexity therapeutic synthesis.

By Product & Service Type

  • Custom Synthesis (Primers & Probes): Continues to be the volume leader, essential for NGS (Next-Generation Sequencing), PCR diagnostics, and synthetic biology.
  • Oligonucleotide APIs (Large Scale): The highest growth segment. Demand is fueled by the commercial success of RNAi and Antisense drugs for chronic conditions like cardiovascular disease and NASH.
  • Reagents & Consumables: A critical recurring revenue stream, including specialized phosphoramidites and solid-phase synthesis supports (CPG).

By Application

  • Therapeutic Applications: Dominates the market value (~55% share). Focus is on Rare Diseases (44% of therapeutic sub-segment), Oncology, and Neurological Disorders.
  • Diagnostic Applications: Driven by the integration of oligonucleotides into liquid biopsy kits and companion diagnostics.
  • Research & Academic: Maintains steady growth through CRISPR-Cas9 advancements and the exploration of DNA-based data storage.

3. Competitive Landscape: Key Players

The landscape is shifting toward consolidated "One-Stop-Shop" CDMOs (Contract Development and Manufacturing Organizations) that can take a molecule from lab bench to commercial launch.

Global Market Leaders

  • Thermo Fisher Scientific Inc. (US) – The market leader (~21% share), providing an end-to-end ecosystem from benchtop synthesizers to industrial-scale GMP manufacturing.
  • Integrated DNA Technologies (IDT/Danaher) (US) – The industry standard for custom high-throughput RUO oligos and long-fragment synthesis (Ultramer™ technology).
  • Agilent Technologies, Inc. (US) – A dominant force in large-scale therapeutic API manufacturing, particularly for FDA-approved ASO drugs.
  • Merck KGaA (Sigma-Aldrich) (Germany) – Leverages a massive global logistics network to provide high-purity reagents and custom oligos for R&D and diagnostics.
  • Eurofins Genomics (Luxembourg/US) – Known for its "Lab-to-Clinic" platform, supporting seamless transitions from research to clinical trial supply.

Strategic Specialists

  • Nitto Denko Avecia Inc. (Japan/US) – A premier CDMO specializing in the scale-up of therapeutic oligonucleotides and delivery technologies.
  • Kaneka Eurogentec S.A. (Belgium) – A leading European producer with a strong focus on diagnostic probes and high-purity peptides.
  • ST Pharm Co., Ltd. (South Korea) – Rapidly expanding Asia's largest nucleic acid API manufacturing capacity to serve global Phase III pipelines.
  • LGC Biosearch Technologies (UK/US) – Specializes in genomic solutions for the agricultural and public health sectors.

4. Regional Analysis

  • North America (44% Share): The largest market, home to the majority of biotech innovators and a favorable regulatory environment for orphan drugs.
  • Europe (28% Share): Stronghold for academic research and a maturing biotech sector in the UK, Germany, and Switzerland.
  • Asia-Pacific (22% Share): The fastest-growing region (CAGR ~20%). China and India are transitioning from low-cost providers to major R&D hubs for homegrown RNA therapies.
  • Rest of the World: Growing interest in Brazil and Saudi Arabia as they invest in local vaccine and genomic manufacturing capabilities.

5. Geopolitical Impact: USA-Israel-Iran Conflict

As of April 2026, the military escalation in the Middle East has introduced significant structural risks to the biotechnology supply chain:

  1. Air Freight Paralysis: Dubai (DXB), a critical hub for temperature-controlled "Cold-Chain" pharma transshipment, has seen major disruptions. Oligonucleotide shipments—which often require -20°C or -80°C stability—are facing backlogs of 5–10 days, leading to a surge in "Temperature Deviation" reports.
  2. API Feedstock Volatility: Many specialty chemical precursors are derived from petrochemical feedstocks. Rerouting sea freight around the Cape of Good Hope has added 15 days to lead times and increased logistics costs by 30–50% for reagents moving between Europe and Asia.
  3. Strategic Nearshoring: To combat "Hormuz Chokepoint" risks, major players like Thermo Fisher and Agilent are accelerating investments in regional manufacturing hubs in the US, Singapore, and Ireland to ensure local supply security.
  4. Operational Resilience: Firms with integrated supply chains (e.g., ST Pharm, Merck) are performing better than those relying on fragmented, just-in-time intermediate deliveries from the Middle East region.

6. Strategic Business Analysis

SWOT Analysis

Strengths

Weaknesses

High specificity of gene-targeting therapies.

High production complexity and "Cold-Chain" sensitivity.

Robust clinical pipeline for previously "undruggable" targets.

Significant chemical waste generation in traditional synthesis.

Opportunities

Threats

Expansion into DNA-based data storage and food production.

Emergence of "Enzymatic Synthesis" (replaces chemicals).

Growing demand for personalized cancer vaccines.

Stringent and evolving GMP regulatory requirements.

Porter’s Five Forces

  1. Bargaining Power of Buyers (High): Large pharmaceutical companies (Eli Lilly, Biogen) use their scale to negotiate multi-year CDMO contracts.
  2. Threat of New Entrants (Low): The capital required for GMP-compliant facilities and specialized IP (e.g., GalNAc conjugation) creates high barriers.
  3. Bargaining Power of Suppliers (Moderate-High): Suppliers of high-purity phosphoramidites hold significant leverage during geopolitical supply crunches.
  4. Competitive Rivalry (Intense): Intense competition in the "Standard RUO" space, while "Therapeutic API" remains a high-margin specialist battleground.

7. Value Chain Analysis

  1. Upstream: Production of specialized phosphoramidites, nucleosides, and solid-support resins (CPG).
  2. Synthesis: Solid-phase phosphoramidite chemistry (or emerging enzymatic methods) to build the nucleotide chain.
  3. Modification & Conjugation: Addition of delivery ligands (e.g., GalNAc, Lipid Nanoparticles) to enhance stability and targeting.
  4. Purification & QC: High-precision HPLC/PAGE purification and mass-spectrometry validation to meet sub-1% impurity thresholds.
  5. Distribution: Global cold-chain logistics to pharmaceutical manufacturers and academic labs.

8. Trend Analysis: "The New Frontier"

  • The "Enzyme Race": A transition from traditional chemical synthesis to Enzymatic DNA Synthesis (EDS), which is water-based and more environmentally friendly.
  • Extra-Hepatic Delivery: Moving beyond liver-targeting (GalNAc) to lipid and cholesterol conjugates that can cross the Blood-Brain Barrier (BBB).
  • AI-Driven Sequence Design: Utilizing machine learning to predict the stability and "off-target" profiles of synthetic oligos before they enter the lab.

9. Quick Recommendations for Stakeholders

  • For Manufacturers: Prioritize investment in Enzymatic Synthesis and green chemistry to hedge against future petrochemical volatility and environmental regulations.
  • For Procurement Managers: Activate dual-sourcing strategies for critical reagents to bypass Middle Eastern maritime chokepoints and ensure continuity of clinical trial supply.
  • For Investors: Focus on mid-sized CDMOs with expertise in conjugation technologies (e.g., GalNAc, PEGylation), as these are the primary differentiators in the 2026 market.
  • For Research Labs: Transition toward long-fragment (>200mer) synthesis to support next-generation CRISPR and synthetic genome projects.

 

Table of Contents

Global Oligonucleotide Synthesis Sales Market Report
1 Oligonucleotide Synthesis Market Overview
    1.1 Product Overview and Scope of Oligonucleotide Synthesis
    1.2 Classification of Oligonucleotide Synthesis by Product Category
        1.2.1 Global Oligonucleotide Synthesis Market Size (Sales) Comparison by Type
        1.2.2 Global Oligonucleotide Synthesis Market Size (Sales) Market Share by Type (Product Category) in
        1.2.3 Primer
        1.2.4 Probe
        1.2.5 Reagent
    1.3 Global Oligonucleotide Synthesis Market by Application/End Users
        1.3.1 Global Oligonucleotide Synthesis Sales (Volume) and Market Share Comparison by Application
        1.3.1 Academic
        1.3.2 Pharmaceutical
        1.3.3 Biotechnology
    1.4 Global Oligonucleotide Synthesis Market by Region
        1.4.1 Global Oligonucleotide Synthesis Market Size (Value) Comparison by Region
        1.4.2 United States Oligonucleotide Synthesis Status and Prospect
        1.4.3 Europe Oligonucleotide Synthesis Status and Prospect
        1.4.4 China Oligonucleotide Synthesis Status and Prospect
        1.4.5 Japan Oligonucleotide Synthesis Status and Prospect
        1.4.6 Southeast Asia Oligonucleotide Synthesis Status and Prospect
        1.4.7 India Oligonucleotide Synthesis Status and Prospect
    1.5 Global Market Size (Value and Volume) of Oligonucleotide Synthesis
        1.5.1 Global Oligonucleotide Synthesis Sales and Growth Rate
        1.5.2 Global Oligonucleotide Synthesis Revenue and Growth Rate

2 Global Oligonucleotide Synthesis Competition by Players/Suppliers, Type and Application
     2.1 Global Oligonucleotide Synthesis Market Competition by Players/Suppliers
        2.1.1 Global Oligonucleotide Synthesis Sales and Market Share of Key Players/Suppliers
        2.1.2 Global Oligonucleotide Synthesis Revenue and Share by Players/Suppliers
    2.2 Global Oligonucleotide Synthesis (Volume and Value) by Type
        2.2.1 Global Oligonucleotide Synthesis Sales and Market Share by Type
        2.2.2 Global Oligonucleotide Synthesis Revenue and Market Share by Type
    2.3 Global Oligonucleotide Synthesis (Volume and Value) by Region
        2.3.1 Global Oligonucleotide Synthesis Sales and Market Share by Region
        2.3.2 Global Oligonucleotide Synthesis Revenue and Market Share by Region
    2.4 Global Oligonucleotide Synthesis (Volume) by Application

3 United States Oligonucleotide Synthesis (Volume, Value and Sales Price)
    3.1 United States Oligonucleotide Synthesis Sales and Value
        3.1.1 United States Oligonucleotide Synthesis Sales and Growth Rate
        3.1.2 United States Oligonucleotide Synthesis Revenue and Growth Rate
        3.1.3 United States Oligonucleotide Synthesis Sales Price Trend
    3.2 United States Oligonucleotide Synthesis Sales Volume and Market Share by Players
    3.3 United States Oligonucleotide Synthesis Sales Volume and Market Share by Type
    3.4 United States Oligonucleotide Synthesis Sales Volume and Market Share by Application

4 Europe Oligonucleotide Synthesis (Volume, Value and Sales Price)
    4.1 Europe Oligonucleotide Synthesis Sales and Value
        4.1.1 Europe Oligonucleotide Synthesis Sales and Growth Rate
        4.1.2 Europe Oligonucleotide Synthesis Revenue and Growth Rate
        4.1.3 Europe Oligonucleotide Synthesis Sales Price Trend
    4.2 Europe Oligonucleotide Synthesis Sales Volume and Market Share by Players
    4.3 Europe Oligonucleotide Synthesis Sales Volume and Market Share by Type
    4.4 Europe Oligonucleotide Synthesis Sales Volume and Market Share by Application

5 China Oligonucleotide Synthesis (Volume, Value and Sales Price)
    5.1 China Oligonucleotide Synthesis Sales and Value
        5.1.1 China Oligonucleotide Synthesis Sales and Growth Rate
        5.1.2 China Oligonucleotide Synthesis Revenue and Growth Rate
        5.1.3 China Oligonucleotide Synthesis Sales Price Trend
    5.2 China Oligonucleotide Synthesis Sales Volume and Market Share by Players
    5.3 China Oligonucleotide Synthesis Sales Volume and Market Share by Type
    5.4 China Oligonucleotide Synthesis Sales Volume and Market Share by Application

6 Japan Oligonucleotide Synthesis (Volume, Value and Sales Price)
    6.1 Japan Oligonucleotide Synthesis Sales and Value
        6.1.1 Japan Oligonucleotide Synthesis Sales and Growth Rate
        6.1.2 Japan Oligonucleotide Synthesis Revenue and Growth Rate
        6.1.3 Japan Oligonucleotide Synthesis Sales Price Trend
    6.2 Japan Oligonucleotide Synthesis Sales Volume and Market Share by Players
    6.3 Japan Oligonucleotide Synthesis Sales Volume and Market Share by Type
    6.4 Japan Oligonucleotide Synthesis Sales Volume and Market Share by Application

7 Southeast Asia Oligonucleotide Synthesis (Volume, Value and Sales Price)
    7.1 Southeast Asia Oligonucleotide Synthesis Sales and Value
        7.1.1 Southeast Asia Oligonucleotide Synthesis Sales and Growth Rate
        7.1.2 Southeast Asia Oligonucleotide Synthesis Revenue and Growth Rate
        7.1.3 Southeast Asia Oligonucleotide Synthesis Sales Price Trend
    7.2 Southeast Asia Oligonucleotide Synthesis Sales Volume and Market Share by Players
    7.3 Southeast Asia Oligonucleotide Synthesis Sales Volume and Market Share by Type
    7.4 Southeast Asia Oligonucleotide Synthesis Sales Volume and Market Share by Application

8 India Oligonucleotide Synthesis (Volume, Value and Sales Price)
    8.1 India Oligonucleotide Synthesis Sales and Value
        8.1.1 India Oligonucleotide Synthesis Sales and Growth Rate
        8.1.2 India Oligonucleotide Synthesis Revenue and Growth Rate
        8.1.3 India Oligonucleotide Synthesis Sales Price Trend
    8.2 India Oligonucleotide Synthesis Sales Volume and Market Share by Players
    8.3 India Oligonucleotide Synthesis Sales Volume and Market Share by Type
    8.4 India Oligonucleotide Synthesis Sales Volume and Market Share by Application

9 Global Oligonucleotide Synthesis Players/Suppliers Profiles and Sales Data
    9.1 INTEGRATED DNA TECHNOLOGIES, INC.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.1.4 Main Business/Business Overview
    9.2 MERCK KGAA
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 MERCK KGAA Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.2.4 Main Business/Business Overview
    9.3 EUROFINS GENOMICS
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 EUROFINS GENOMICS Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.3.4 Main Business/Business Overview
    9.4 THERMO FISHER SCIENTIFIC INC.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.4.4 Main Business/Business Overview
    9.5 BIOAUTOMATION CORPORATION
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.5.4 Main Business/Business Overview
    9.6 AGILENT TECHNOLOGIES, INC.
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.6.4 Main Business/Business Overview
    9.7 EUROGENTEC S.A.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 EUROGENTEC S.A. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.7.4 Main Business/Business Overview
    9.8 GENERAL ELECTRIC (GE) COMPANY
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.8.4 Main Business/Business Overview
    9.9 LGC BIOSEARCH TECHNOLOGIES, INC.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.9.4 Main Business/Business Overview
    9.10 NITTO DENKO AVECIA INC.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Oligonucleotide Synthesis Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin
        9.10.4 Main Business/Business Overview

10 Oligonucleotide Synthesis Maufacturing Cost Analysis
    10.1 Oligonucleotide Synthesis Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Oligonucleotide Synthesis
    10.3 Manufacturing Process Analysis of Oligonucleotide Synthesis

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Oligonucleotide Synthesis Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Oligonucleotide Synthesis Market Forecast
    14.1 Global Oligonucleotide Synthesis Sales Volume, Revenue and Price Forecast
       14.1.1 Global Oligonucleotide Synthesis Sales Volume and Growth Rate Forecast
       14.1.2 Global Oligonucleotide Synthesis Revenue and Growth Rate Forecast
       14.1.3 Global Oligonucleotide Synthesis Price and Trend Forecast
    14.2 Global Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast by Region
       14.2.1 Global Oligonucleotide Synthesis Sales Volume and Growth Rate Forecast by Regions
       14.2.2 Global Oligonucleotide Synthesis Revenue and Growth Rate Forecast by Regions
       14.2.3 United States Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast
       14.2.4 Europe Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast
       14.2.5 China Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast
       14.2.6 Japan Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast
       14.2.7 Southeast Asia Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast
       14.2.8 India Oligonucleotide Synthesis Sales Volume, Revenue and Growth Rate Forecast
    14.3 Global Oligonucleotide Synthesis Sales Volume, Revenue and Price Forecast by Type
       14.3.1 Global Oligonucleotide Synthesis Sales Forecast by Type
       14.3.2 Global Oligonucleotide Synthesis Revenue Forecast by Type
       14.3.3 Global Oligonucleotide Synthesis Price Forecast by Type
    14.4 Global Oligonucleotide Synthesis Sales Volume Forecast by Application

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer
List of Tables and Figures

    Figure Product Picture of Oligonucleotide Synthesis
    Figure Global Oligonucleotide Synthesis Sales Volume Comparison (K Units) by Type
    Figure Global Oligonucleotide Synthesis Sales Volume Market Share by Type (Product Category) in
    Figure Primer Product Picture
    Figure Probe Product Picture
    Figure Reagent Product Picture
    Figure Global Oligonucleotide Synthesis Sales Comparison (K Units) by Application
    Figure Global Sales Market Share of Oligonucleotide Synthesis by Application in
    Figure Academic Examples
    Table Key Downstream Customer in Academic
    Figure Pharmaceutical Examples
    Table Key Downstream Customer in Pharmaceutical
    Figure Biotechnology Examples
    Table Key Downstream Customer in Biotechnology
    Figure Global Oligonucleotide Synthesis Market Size (Million USD) by Regions
    Figure United States Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Europe Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure China Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Japan Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Southeast Asia Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure India Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Global Oligonucleotide Synthesis Sales Volume (K Units) and Growth Rate
    Figure Global Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Global Market Major Players Oligonucleotide Synthesis Sales Volume (K Units)
    Table Global Oligonucleotide Synthesis Sales (K Units) of Key Players/Suppliers
    Table Global Oligonucleotide Synthesis Sales Share by Players/Suppliers
    Figure  Oligonucleotide Synthesis Sales Share by Players/Suppliers
    Figure  Oligonucleotide Synthesis Sales Share by Players/Suppliers
    Figure Global Oligonucleotide Synthesis Revenue (Million USD) by Players/Suppliers
    Table Global Oligonucleotide Synthesis Revenue (Million USD) by Players/Suppliers
    Table Global Oligonucleotide Synthesis Revenue Share by Players/Suppliers
    Table  Global Oligonucleotide Synthesis Revenue Share by Players
    Table  Global Oligonucleotide Synthesis Revenue Share by Players
    Table Global Oligonucleotide Synthesis Sales (K Units) and Market Share by Type
    Table Global Oligonucleotide Synthesis Sales Share (K Units) by Type
    Figure Sales Market Share of Oligonucleotide Synthesis by Type
    Figure Global Oligonucleotide Synthesis Sales Growth Rate by Type
    Table Global Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Type
    Table Global Oligonucleotide Synthesis Revenue Share by Type
    Figure Revenue Market Share of Oligonucleotide Synthesis by Type
    Figure Global Oligonucleotide Synthesis Revenue Growth Rate by Type
    Table Global Oligonucleotide Synthesis Sales Volume (K Units) and Market Share by Region
    Table Global Oligonucleotide Synthesis Sales Share by Region
    Figure Sales Market Share of Oligonucleotide Synthesis by Region
    Figure Global Oligonucleotide Synthesis Sales Growth Rate by Region in
    Table Global Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Region
    Table Global Oligonucleotide Synthesis Revenue Share (%) by Region
    Figure Revenue Market Share of Oligonucleotide Synthesis by Region
    Figure Global Oligonucleotide Synthesis Revenue Growth Rate by Region in
    Table Global Oligonucleotide Synthesis Revenue (Million USD) and Market Share by Region
    Table Global Oligonucleotide Synthesis Revenue Share (%) by Region
    Figure Revenue Market Share of Oligonucleotide Synthesis by Region
    Figure Global Oligonucleotide Synthesis Revenue Market Share by Region in
    Table Global Oligonucleotide Synthesis Sales Volume (K Units) and Market Share by Application
    Table Global Oligonucleotide Synthesis Sales Share (%) by Application
    Figure Sales Market Share of Oligonucleotide Synthesis by Application
    Figure Global Oligonucleotide Synthesis Sales Market Share by Application
    Figure United States Oligonucleotide Synthesis Sales (K Units) and Growth Rate
    Figure United States Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure United States Oligonucleotide Synthesis Sales Price (USD/Unit) Trend
    Table United States Oligonucleotide Synthesis Sales Volume (K Units) by Players
    Table United States Oligonucleotide Synthesis Sales Volume Market Share by Players
    Figure United States Oligonucleotide Synthesis Sales Volume Market Share by Players in
    Table United States Oligonucleotide Synthesis Sales Volume (K Units) by Type
    Table United States Oligonucleotide Synthesis Sales Volume Market Share by Type
    Figure United States Oligonucleotide Synthesis Sales Volume Market Share by Type in
    Table United States Oligonucleotide Synthesis Sales Volume (K Units) by Application
    Table United States Oligonucleotide Synthesis Sales Volume Market Share by Application
    Figure United States Oligonucleotide Synthesis Sales Volume Market Share by Application in
    Figure Europe Oligonucleotide Synthesis Sales (K Units) and Growth Rate
    Figure Europe Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Europe Oligonucleotide Synthesis Sales Price (USD/Unit) Trend
    Table Europe Oligonucleotide Synthesis Sales Volume (K Units) by Players
    Table Europe Oligonucleotide Synthesis Sales Volume Market Share by Players
    Figure Europe Oligonucleotide Synthesis Sales Volume Market Share by Players in
    Table Europe Oligonucleotide Synthesis Sales Volume (K Units) by Type
    Table Europe Oligonucleotide Synthesis Sales Volume Market Share by Type
    Figure Europe Oligonucleotide Synthesis Sales Volume Market Share by Type in
    Table Europe Oligonucleotide Synthesis Sales Volume (K Units) by Application
    Table Europe Oligonucleotide Synthesis Sales Volume Market Share by Application
    Figure Europe Oligonucleotide Synthesis Sales Volume Market Share by Application in
    Figure China Oligonucleotide Synthesis Sales (K Units) and Growth Rate
    Figure China Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure China Oligonucleotide Synthesis Sales Price (USD/Unit) Trend
    Table China Oligonucleotide Synthesis Sales Volume (K Units) by Players
    Table China Oligonucleotide Synthesis Sales Volume Market Share by Players
    Figure China Oligonucleotide Synthesis Sales Volume Market Share by Players in
    Table China Oligonucleotide Synthesis Sales Volume (K Units) by Type
    Table China Oligonucleotide Synthesis Sales Volume Market Share by Type
    Figure China Oligonucleotide Synthesis Sales Volume Market Share by Type in
    Table China Oligonucleotide Synthesis Sales Volume (K Units) by Application
    Table China Oligonucleotide Synthesis Sales Volume Market Share by Application
    Figure China Oligonucleotide Synthesis Sales Volume Market Share by Application in
    Figure Japan Oligonucleotide Synthesis Sales (K Units) and Growth Rate
    Figure Japan Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Japan Oligonucleotide Synthesis Sales Price (USD/Unit) Trend
    Table Japan Oligonucleotide Synthesis Sales Volume (K Units) by Players
    Table Japan Oligonucleotide Synthesis Sales Volume Market Share by Players
    Figure Japan Oligonucleotide Synthesis Sales Volume Market Share by Players in
    Table Japan Oligonucleotide Synthesis Sales Volume (K Units) by Type
    Table Japan Oligonucleotide Synthesis Sales Volume Market Share by Type
    Figure Japan Oligonucleotide Synthesis Sales Volume Market Share by Type in
    Table Japan Oligonucleotide Synthesis Sales Volume (K Units) by Application
    Table Japan Oligonucleotide Synthesis Sales Volume Market Share by Application
    Figure Japan Oligonucleotide Synthesis Sales Volume Market Share by Application in
    Figure Southeast Asia Oligonucleotide Synthesis Sales (K Units) and Growth Rate
    Figure Southeast Asia Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure Southeast Asia Oligonucleotide Synthesis Sales Price (USD/Unit) Trend
    Table Southeast Asia Oligonucleotide Synthesis Sales Volume (K Units) by Players
    Table Southeast Asia Oligonucleotide Synthesis Sales Volume Market Share by Players
    Figure Southeast Asia Oligonucleotide Synthesis Sales Volume Market Share by Players in
    Table Southeast Asia Oligonucleotide Synthesis Sales Volume (K Units) by Type
    Table Southeast Asia Oligonucleotide Synthesis Sales Volume Market Share by Type
    Figure Southeast Asia Oligonucleotide Synthesis Sales Volume Market Share by Type in
    Table Southeast Asia Oligonucleotide Synthesis Sales Volume (K Units) by Application
    Table Southeast Asia Oligonucleotide Synthesis Sales Volume Market Share by Application
    Figure Southeast Asia Oligonucleotide Synthesis Sales Volume Market Share by Application in
    Figure India Oligonucleotide Synthesis Sales (K Units) and Growth Rate
    Figure India Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate
    Figure India Oligonucleotide Synthesis Sales Price (USD/Unit) Trend
    Table India Oligonucleotide Synthesis Sales Volume (K Units) by Players
    Table India Oligonucleotide Synthesis Sales Volume Market Share by Players
    Figure India Oligonucleotide Synthesis Sales Volume Market Share by Players in
    Table India Oligonucleotide Synthesis Sales Volume (K Units) by Type
    Table India Oligonucleotide Synthesis Sales Volume Market Share by Type
    Figure India Oligonucleotide Synthesis Sales Volume Market Share by Type in
    Table India Oligonucleotide Synthesis Sales Volume (K Units) by Application
    Table India Oligonucleotide Synthesis Sales Volume Market Share by Application
    Figure India Oligonucleotide Synthesis Sales Volume Market Share by Application in
    Table INTEGRATED DNA TECHNOLOGIES, INC. Basic Information List
    Table INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Growth Rate
    Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Global Market Share
    Figure INTEGRATED DNA TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Global Market Share
    Table MERCK KGAA Basic Information List
    Table MERCK KGAA Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure MERCK KGAA Oligonucleotide Synthesis Sales Growth Rate
    Figure MERCK KGAA Oligonucleotide Synthesis Sales Global Market Share
    Figure MERCK KGAA Oligonucleotide Synthesis Revenue Global Market Share
    Table EUROFINS GENOMICS Basic Information List
    Table EUROFINS GENOMICS Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure EUROFINS GENOMICS Oligonucleotide Synthesis Sales Growth Rate
    Figure EUROFINS GENOMICS Oligonucleotide Synthesis Sales Global Market Share (-
    Figure EUROFINS GENOMICS Oligonucleotide Synthesis Revenue Global Market Share
    Table THERMO FISHER SCIENTIFIC INC. Basic Information List
    Table THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales Growth Rate
    Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Sales Global Market Share
    Figure THERMO FISHER SCIENTIFIC INC. Oligonucleotide Synthesis Revenue Global Market Share
    Table BIOAUTOMATION CORPORATION Basic Information List
    Table BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales Growth Rate
    Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Sales Global Market Share
    Figure BIOAUTOMATION CORPORATION Oligonucleotide Synthesis Revenue Global Market Share
    Table AGILENT TECHNOLOGIES, INC. Basic Information List
    Table AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Growth Rate
    Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Global Market Share (-
    Figure AGILENT TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Global Market Share
    Table EUROGENTEC S.A. Basic Information List
    Table EUROGENTEC S.A. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure EUROGENTEC S.A. Oligonucleotide Synthesis Sales Growth Rate
    Figure EUROGENTEC S.A. Oligonucleotide Synthesis Sales Global Market Share
    Figure EUROGENTEC S.A. Oligonucleotide Synthesis Revenue Global Market Share
    Table GENERAL ELECTRIC (GE) COMPANY Basic Information List
    Table GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales Growth Rate
    Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Sales Global Market Share (-
    Figure GENERAL ELECTRIC (GE) COMPANY Oligonucleotide Synthesis Revenue Global Market Share
    Table LGC BIOSEARCH TECHNOLOGIES, INC. Basic Information List
    Table LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Growth Rate
    Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Sales Global Market Share
    Figure LGC BIOSEARCH TECHNOLOGIES, INC. Oligonucleotide Synthesis Revenue Global Market Share
    Table NITTO DENKO AVECIA INC. Basic Information List
    Table NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin
    Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales Growth Rate
    Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Sales Global Market Share
    Figure NITTO DENKO AVECIA INC. Oligonucleotide Synthesis Revenue Global Market Share
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Oligonucleotide Synthesis
    Figure Manufacturing Process Analysis of Oligonucleotide Synthesis
    Figure Oligonucleotide Synthesis Industrial Chain Analysis
    Table Raw Materials Sources of Oligonucleotide Synthesis Major Players in
    Table Major Buyers of Oligonucleotide Synthesis
    Table Distributors/Traders List
    Figure Global Oligonucleotide Synthesis Sales Volume (K Units) and Growth Rate Forecast
    Figure Global Oligonucleotide Synthesis Revenue (Million USD) and Growth Rate Forecast
    Figure Global Oligonucleotide Synthesis Price (USD/Unit) and Trend Forecast
    Table Global Oligonucleotide Synthesis Sales Volume (K Units) Forecast by Regions
    Figure Global Oligonucleotide Synthesis Sales Volume Market Share Forecast by Regions
    Figure Global Oligonucleotide Synthesis Sales Volume Market Share Forecast by Regions in
    Table Global Oligonucleotide Synthesis Revenue (Million USD) Forecast by Regions
    Figure Global Oligonucleotide Synthesis Revenue Market Share Forecast by Regions
    Figure Global Oligonucleotide Synthesis Revenue Market Share Forecast by Regions in
    Figure United States Oligonucleotide Synthesis Sales Volum

Segments Analysis

The market is bifurcating into high-throughput "Digital DNA" services and high-complexity therapeutic synthesis.

By Product & Service Type

  • Custom Synthesis (Primers & Probes): Continues to be the volume leader, essential for NGS (Next-Generation Sequencing), PCR diagnostics, and synthetic biology.
  • Oligonucleotide APIs (Large Scale): The highest growth segment. Demand is fueled by the commercial success of RNAi and Antisense drugs for chronic conditions like cardiovascular disease and NASH.
  • Reagents & Consumables: A critical recurring revenue stream, including specialized phosphoramidites and solid-phase synthesis supports (CPG).

By Application

  • Therapeutic Applications: Dominates the market value (~55% share). Focus is on Rare Diseases (44% of therapeutic sub-segment), Oncology, and Neurological Disorders.
  • Diagnostic Applications: Driven by the integration of oligonucleotides into liquid biopsy kits and companion diagnostics.
  • Research & Academic: Maintains steady growth through CRISPR-Cas9 advancements and the exploration of DNA-based data storage.

3. Competitive Landscape: Key Players

The landscape is shifting toward consolidated "One-Stop-Shop" CDMOs (Contract Development and Manufacturing Organizations) that can take a molecule from lab bench to commercial launch.

Global Market Leaders

  • Thermo Fisher Scientific Inc. (US) – The market leader (~21% share), providing an end-to-end ecosystem from benchtop synthesizers to industrial-scale GMP manufacturing.
  • Integrated DNA Technologies (IDT/Danaher) (US) – The industry standard for custom high-throughput RUO oligos and long-fragment synthesis (Ultramer™ technology).
  • Agilent Technologies, Inc. (US) – A dominant force in large-scale therapeutic API manufacturing, particularly for FDA-approved ASO drugs.
  • Merck KGaA (Sigma-Aldrich) (Germany) – Leverages a massive global logistics network to provide high-purity reagents and custom oligos for R&D and diagnostics.
  • Eurofins Genomics (Luxembourg/US) – Known for its "Lab-to-Clinic" platform, supporting seamless transitions from research to clinical trial supply.

Strategic Specialists

  • Nitto Denko Avecia Inc. (Japan/US) – A premier CDMO specializing in the scale-up of therapeutic oligonucleotides and delivery technologies.
  • Kaneka Eurogentec S.A. (Belgium) – A leading European producer with a strong focus on diagnostic probes and high-purity peptides.
  • ST Pharm Co., Ltd. (South Korea) – Rapidly expanding Asia's largest nucleic acid API manufacturing capacity to serve global Phase III pipelines.
  • LGC Biosearch Technologies (UK/US) – Specializes in genomic solutions for the agricultural and public health sectors.

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.


Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.


Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.


Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.


Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.